The fight against COVID19
23.85k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | - | - | - | - |
| ^GSPC | +0.60% | +3.36% | +34.37% | +6152.72% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 161.46 | +0.95 | +0.59% | 4:00 pm GMT-4 | 5.25M | 6.55M | 388.67B |
| ABBV | AbbVie Inc. | 194.19 | -0.16 | -0.08% | 4:00 pm GMT-4 | 2.09M | 4.71M | 343.01B |
| PFE | Pfizer Inc. | 29.16 | -0.18 | -0.61% | 4:00 pm GMT-4 | 29.58M | 31.95M | 165.24B |
| SNY | Sanofi | 54.96 | +0.19 | +0.35% | 4:00 pm GMT-4 | 1.57M | 1.80M | 137.98B |
| REGN | Regeneron Pharmaceuticals, Inc. | 1015.67 | +16.65 | +1.67% | 4:00 pm GMT-4 | 474.08k | 536.85k | 111.96B |
| GILD | Gilead Sciences, Inc. | 84.95 | +0.28 | +0.33% | 4:00 pm GMT-4 | 3.98M | 6.44M | 105.76B |
| GSK | GSK plc | 38.83 | -0.38 | -0.97% | 4:00 pm GMT-4 | 7.24M | 4.00M | 80.22B |
| TAK | Takeda Pharmaceutical Company Limited | 14.3 | -0.01 | -0.07% | 4:00 pm GMT-4 | 3.16M | 2.26M | 45.40B |
| BNTX | BioNTech SE | 120.52 | +2.15 | +1.82% | 4:00 pm GMT-4 | 445.81k | 955.89k | 28.66B |
| MRNA | Moderna, Inc. | 58.29 | +1.46 | +2.57% | 4:00 pm GMT-4 | 6.25M | 4.77M | 22.41B |
| NVAX | Novavax, Inc. | 12.53 | -0.38 | -2.91% | 4:00 pm GMT-4 | 5.74M | 6.72M | 2.01B |
| VIR | Vir Biotechnology, Inc. | 7.59 | +0.25 | +3.41% | 4:00 pm GMT-4 | 688.67k | 774.51k | 1.04B |
| INO | Inovio Pharmaceuticals, Inc. | 5.75 | +0.34 | +6.28% | 4:00 pm GMT-4 | 479.32k | 319.57k | 149.29M |
- TechCrunch
'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup
In January last year, German biotech company BioNTech acquired African AI startup Instadeep for over $550 million, a deal finalized in July of the same year. Instadeep, whose exit is currently the largest from Africa, has been operating under the German pharma umbrella for just over a year. Now is a good time to look at how it has fared since the acquisition. Instadeep uses advanced machine learning techniques to bring AI into enterprise applications. Its products range from GPU-accelerated insi
Simply Wall St.The past three years for Pfizer (NYSE:PFE) investors has not been profitable
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
Motley Fool2 Unstoppable Growth Stocks to Buy Right Now for Less than $200
These businesses are trading at discounts right now.
